BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 11027413)

  • 1. Rational basis for Trk inhibition therapy for prostate cancer.
    Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
    Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis.
    Bellanger C; Dubanet L; Lise MC; Fauchais AL; Bordessoule D; Jauberteau MO; Troutaud D
    PLoS One; 2011; 6(11):e27213. PubMed ID: 22076137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate.
    Dalal R; Djakiew D
    Mol Cell Endocrinol; 1997 Oct; 134(1):15-22. PubMed ID: 9406845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pacinian corpuscle development involves multiple Trk signaling pathways.
    Sedý J; Szeder V; Walro JM; Ren ZG; Nanka O; Tessarollo L; Sieber-Blum M; Grim M; Kucera J
    Dev Dyn; 2004 Nov; 231(3):551-63. PubMed ID: 15376326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophin effects on neuroblastoma cells: correlation with trk and p75NTR expression and influence of Trk receptor bodies.
    Evangelopoulos ME; Weis J; Kruttgen A
    J Neurooncol; 2004 Jan; 66(1-2):101-10. PubMed ID: 15015775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
    Lawn S; Krishna N; Pisklakova A; Qu X; Fenstermacher DA; Fournier M; Vrionis FD; Tran N; Chan JA; Kenchappa RS; Forsyth PA
    J Biol Chem; 2015 Feb; 290(6):3814-24. PubMed ID: 25538243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
    Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
    Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth.
    Delsite R; Djakiew D
    Prostate; 1999 Sep; 41(1):39-48. PubMed ID: 10440874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
    Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
    Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer.
    Ketterer K; Rao S; Friess H; Weiss J; Büchler MW; Korc M
    Clin Cancer Res; 2003 Nov; 9(14):5127-36. PubMed ID: 14613990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.
    Perez-Pinera P; Hernandez T; García-Suárez O; de Carlos F; Germana A; Del Valle M; Astudillo A; Vega JA
    Mol Cell Biochem; 2007 Jan; 295(1-2):19-26. PubMed ID: 16862449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fates of neurotrophins after retrograde axonal transport: phosphorylation of p75NTR is a sorting signal for delayed degradation.
    Butowt R; von Bartheld CS
    J Neurosci; 2009 Aug; 29(34):10715-29. PubMed ID: 19710323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
    Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
    Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling.
    Ceni C; Kommaddi RP; Thomas R; Vereker E; Liu X; McPherson PS; Ritter B; Barker PA
    J Cell Sci; 2010 Jul; 123(Pt 13):2299-307. PubMed ID: 20530577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophins induce sphingomyelin hydrolysis. Modulation by co-expression of p75NTR with Trk receptors.
    Dobrowsky RT; Jenkins GM; Hannun YA
    J Biol Chem; 1995 Sep; 270(38):22135-42. PubMed ID: 7673191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
    Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects.
    Raap U; Deneka N; Bruder M; Kapp A; Wedi B
    Clin Exp Allergy; 2008 Sep; 38(9):1493-8. PubMed ID: 18647313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p75 Co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains.
    Zaccaro MC; Ivanisevic L; Perez P; Meakin SO; Saragovi HU
    J Biol Chem; 2001 Aug; 276(33):31023-9. PubMed ID: 11425862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the inhibitors of myelin with a novel neurotrophin strategy.
    Williams G; Williams EJ; Maison P; Pangalos MN; Walsh FS; Doherty P
    J Biol Chem; 2005 Feb; 280(7):5862-9. PubMed ID: 15572360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the nerve growth factor network in prostate cancer.
    Papatsoris AG; Liolitsa D; Deliveliotis C
    Expert Opin Investig Drugs; 2007 Mar; 16(3):303-9. PubMed ID: 17302525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.